98 related articles for article (PubMed ID: 21262310)
1. Impact of pronase on flow cytometric crossmatch outcome.
Hetrick SJ; Schillinger KP; Zachary AA; Jackson AM
Hum Immunol; 2011 Apr; 72(4):330-6. PubMed ID: 21262310
[TBL] [Abstract][Full Text] [Related]
2. Frequent false-positive reactions in pronase-treated T-cell flow cytometric cross-match tests.
Park H; Lim YM; Han BY; Hyun J; Song EY; Park MH
Transplant Proc; 2012 Jan; 44(1):87-90. PubMed ID: 22310587
[TBL] [Abstract][Full Text] [Related]
3. Impact of rituximab on the T-cell flow cytometric crossmatch.
Doss SA; Mittal S; Daniel D
Transpl Immunol; 2021 Feb; 64():101360. PubMed ID: 33359130
[TBL] [Abstract][Full Text] [Related]
4. Positive B-cell only flow cytometric crossmatch: implications for renal transplantation.
Delgado JC; Eckels DD
Exp Mol Pathol; 2008 Aug; 85(1):59-63. PubMed ID: 18499103
[TBL] [Abstract][Full Text] [Related]
5. Improved flow cytometric detection of HLA alloantibodies using pronase: potential implications in renal transplantation.
Vaidya S; Cooper TY; Avandsalehi J; Barnes T; Brooks K; Hymel P; Noor M; Sellers R; Thomas A; Stewart D; Daller J; Fish JC; Gugliuzza KK; Bray RA
Transplantation; 2001 Feb; 71(3):422-8. PubMed ID: 11233905
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometry crossmatch reactivity with pronase-treated T cells induced by non-HLA autoantibodies in human immunodeficiency virus-infected patients.
Szewczyk K; Barrios K; Magas D; Sieg K; Labuda B; Jendrisak MD; Jaramillo A
Hum Immunol; 2016 Jun; 77(6):449-55. PubMed ID: 27094930
[TBL] [Abstract][Full Text] [Related]
7. Improved specificity and sensitivity when using pronase-digested lymphocytes to perform flow-cytometric crossmatch prior to renal transplantation.
Lobo PI; Isaacs RB; Spencer CE; Pruett TL; Sanfey HA; Sawyer RG; McCullough C
Transpl Int; 2002 Nov; 15(11):563-9. PubMed ID: 12461661
[TBL] [Abstract][Full Text] [Related]
8. Relevance of posttransplant flow cytometric T- and B-cell crossmatches in tacrolimus-treated renal transplant patients.
Lenaers JI; Christiaans MH; Voorter CE; van Hooff HP; van den Berg-Loonen EM
Transplantation; 2006 Nov; 82(9):1142-7. PubMed ID: 17102764
[TBL] [Abstract][Full Text] [Related]
9. The effect of antithymocyte globulin on anti-human leukocyte antigen antibody detection assays.
Gloor JM; Moore SB; Schneider BA; Degoey SR; Stegall MD
Transplantation; 2007 Jul; 84(2):258-64. PubMed ID: 17667819
[TBL] [Abstract][Full Text] [Related]
10. Pronase treatment facilitates alloantibody flow cytometric and cytotoxic crossmatching in the presence of rituximab.
Bearden CM; Agarwal A; Book BK; Sidner RA; Gebel HM; Bray RA; Pescovitz MD
Hum Immunol; 2004 Aug; 65(8):803-9. PubMed ID: 15336781
[TBL] [Abstract][Full Text] [Related]
11. The flow cytometric crossmatch. Dual-color analysis of T cell and B cell reactivities.
Bray RA; Lebeck LK; Gebel HM
Transplantation; 1989 Nov; 48(5):834-40. PubMed ID: 2815255
[TBL] [Abstract][Full Text] [Related]
12. A flow cytometric crossmatch test for simultaneous detection of antibodies against donor lymphocytes and endothelial precursor cells.
Alheim M; Johansson SM; Hauzenberger D; Grufman P; Holgersson J
Tissue Antigens; 2010 Mar; 75(3):269-77. PubMed ID: 20070600
[TBL] [Abstract][Full Text] [Related]
13. Reanalysis of the role of pronase treatment of B cells in the flow cytometric crossmatch assay: Fc receptor is not the primary target.
Brown NK; Meade JR; Wang J; Marino SR
Hum Immunol; 2017 Nov; 78(11-12):704-709. PubMed ID: 28987959
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of a positive flow crossmatch on the outcomes of cadaveric renal transplants.
Ilham MA; Winkler S; Coates E; Rizzello A; Rees TJ; Asderakis A
Transplant Proc; 2008; 40(6):1839-43. PubMed ID: 18675065
[TBL] [Abstract][Full Text] [Related]
15. Low Expression Loci and the Use of Pronase in Flow Cytometry Crossmatch.
Silva C; Aires P; Santo P; Xavier P
Transplant Proc; 2023; 55(6):1383-1389. PubMed ID: 37173263
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometry crossmatching and primary cadaver kidney graft outcome: relevance of T and B cell targets, historic sera and autologous controls.
LeFor WM; Ackermann JR; Alveranga DY; Bowers VD; Heinrichs DF; Kahana L; Shires DL; Weinstein SS; Wright CE
Clin Transplant; 1996 Dec; 10(6 Pt 2):601-6. PubMed ID: 8996750
[TBL] [Abstract][Full Text] [Related]
17. Pronase independent flow cytometry crossmatching of rituximab treated patients.
Alheim M; Wennberg L; Wikström AC
Hum Immunol; 2018 Feb; 79(2):132-135. PubMed ID: 29157993
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometric crossmatch for kidney transplantation.
Koktathong K; Vejbaesya S; Bejrachandra S; Pattanapanyasat K
J Med Assoc Thai; 2005 Jun; 88(6):769-74. PubMed ID: 16083217
[TBL] [Abstract][Full Text] [Related]
19. T-cell flow-cytometry crossmatch and long-term renal graft survival.
Rebibou JM; Bittencourt MC; Saint-Hillier Y; Chabod J; Dupont I; Bittard H; Chalopin JM; Hervé P; Tiberghien P
Clin Transplant; 2004 Oct; 18(5):558-63. PubMed ID: 15344960
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometry crossmatching (FCXM) in the UNOS Kidney Transplant Registry.
Cook DJ; Fettouh HI; Gjertson DW; Cecka JM
Clin Transpl; 1998; ():413-9. PubMed ID: 10503119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
